KAT-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KAT-101, covering 2025-06-05 to 2025-06-05. Get the full timeline:
Most recent: Clinical Trial Update: KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]